integrating novel agents into the treatment of multiple myeloma
Published 9 years ago • 44 plays • Length 2:09Download video MP4
Download video MP3
Similar videos
-
3:24
novel agents for the management of r/r myeloma
-
0:48
asciminib for the treatment of cml
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
2:45
continuity of care for patients with hematological predispositions to aml
-
2:42
hdac8: a novel therapeutic target in multiple myeloma
-
8:11
what is hematology oncology?
-
5:13
what is a haematologist?
-
22:38
introduction to haematology part 1
-
1:21
trends in allosct for good-risk aml: a longitudinal study
-
2:00
the development of anti-fibrotic agents for treating myelofibrosis
-
1:50
real-world outcomes of teclistamab treatment in r/r multiple myeloma
-
4:45
a first-in-human trial of linvoseltamab (regn5458) in r/r myeloma: updated phase i data
-
7:07
multiple myeloma coverage on vjhemonc!
-
0:56
the evolving treatment landscape in pv
-
1:22
an all-molecular diagnostic approach for myeloma
-
1:17
novel agents to improve outcomes for patients with multiple myeloma in the salvage setting
-
2:25
novel ai model for personalized risk stratification & treatment in newly diagnosed multiple myeloma
-
1:50
molecular characteristics of extramedullary myeloma
-
2:05
alnuctamab: improved route of administration and optimized dose level & dosing schedule
-
5:46
determination: results & implications in clinical practice
-
3:01
novel promising agents and clinical trials in amyloidosis
-
2:41
an overview of the latest advances in hematology